Today’s shifting regulatory environment continues to exert mounting pressure upon the pharmaceutical industry. In a recent meeting with Congress, the FDA presented draft guidance seeking to modernize drug manufacturing. The suggestions encourage life sciences firms to adopt emerging technologies to improve drug quality. Poor quality can lead to costly recalls stemming from a variety of failures such as compromised sterility, mold in manufacturing areas and contaminated containers. It can even result in delayed product launches. In addition to the potential health risks, these delays and recalls contribute to shortages, which can prevent life-saving drugs from reaching the patients who need them.

In today’s globalized world, emerging markets are playing an increasingly important role. Emerging markets are countries that are right on the edge of becoming developed markets. Traditionally, the term was used to describe the four BRIC countries—Brazil, Russia, India and China—but as economic conditions in Latin America and the Asia-Pacific […]

Attention to detail is par for the course within most modern industries and fields, including scientific research. In addition to finding ways to remain competitive in today’s crowded market and maintaining margins in the face of rising R&D costs, life science organizations now have to take into consideration more regulatory […]

It seems like individuals are constantly considering changes to lifestyle as a result of evolving advice. From incorporating a new food into a diet because it’s considered healthier to switching to a different type of exercise because it’s better for the knees, there is no doubt about it—managing lifestyles can be challenging. Despite all that, however, one thing remains the same: my home must be cleaned. The same is true for other people, too. A recent global survey found that 31% of people cleaned their households every day.

It’s hard to believe that last month marked the third anniversary of the West Fertilizer Company explosion. In some ways, it seems just like yesterday that the disaster dominated headlines. But enough time has passed that we’ve seen the passage of multiple bills seeking to prevent another deadly accident of […]

Over the past few years, the medical community’s approach to healthcare has changed. If you’ve visited your primary care physician within the last year or two, no doubt you’ve experienced firsthand the increased emphasis on preventative medicine. Some advice you might have received likely included exercise more, lose weight and watch your diet. With obesity rates in the United States skyrocketing, this renewed focus isn’t surprising—especially in light of the fact that obesity is linked to chronic conditions such as cardiovascular disease and metabolic disorders. One of these chronic diseases is type-2 diabetes, which is initially treated with a regimen similar to the one used to prevent obesity. Due to the connection between the two conditions, the overlap makes sense. In fact, preventing obesity is considered the first step to lowering your chances of developing type-2 diabetes. Like obesity, weight management through diet and exercise isn’t always an effective form of type-2 diabetes treatment. When these methods fail, patients often then turn to other therapies such as medication or insulin shots to control glucose levels. But with the price of insulin rising, there has been an increased interest in finding alternative type-2 diabetes treatment options.

Page 24 of 99« First...10...2223242526...304050...Last »